Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CVS stock got burned surprisingly badly during the bear market. Its dividend yield is currently higher than it's likely to be in the long term.

Is Now a Smart Time to Buy the Dip in CVS Stock?

Combined companies will deliver a superior health care experience and drive improved health outcomes WOONSOCKET, R.I. , March 29, 2023 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that it has completed its acquisition of Signify Health.

CVS Health Completes Acquisition of Signify Health

Teladoc

Weightwatchers International Inc.

Healthcare tends to be a great place to hide during periods of uncertainty, and considering the best telehealth stocks to buy is one way to do more than just hide. There are several big trends emerging in healthcare right now, and most point to growth in online, at-home medical attention.

3 Top Stock Picks to Profit From the Telehealth Boom

According to CVS Health (CVS), Signify Health, a leading healthcare platform, is set to play a critical role in advancing its healthcare services strategy.

CVS Health (CVS) Nears Completion of $8B SGFY Acquisition

Bank of America

Given the macro backdrop and confounding sector rotations, 2022 has been tough sledding for many investors. Adversity breeds opportunity.

A Double Play For A Rugged Tape

Signify Health

CVS Health said it will close its $8 billion acquisition of Signify Health, bringing the drugstore giant in-home medical services from a national network of clinicians.

CVS To Close Signify Health Deal, Launching A National In-Home Care Business

WOONSOCKET, R.I. and DALLAS and NEW YORK , March 27, 2023 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced it expects to complete its acquisition of Signify Health (NYSE: SGFY) on or around March 29, 2023, subject to the satisfaction or waiver of the remaining customary closing conditions set forth in the merger agreement.

CVS Health to Close Acquisition of Signify Health

CVS has piled on debt to reinvent its business. The stock's been sold off in this high-interest-rate environment.

This Boring Business Could Be a Secret Weapon to Beat the Market

3.25% dividend yield, strong free cash generation. Oak Street acquisition projected to add $2 billion in EBITDA by 2026.

3.25% Yield And Healthcare Repositioning For CVS Health

Devon Energy

Medical Properties Trust

Devon Energy's shares could jump if oil prices rise this summer, as some experts predict. CVS Health should see its earnings increase once the pending acquisition of Oak Street Health closes.

3 Dividend Stocks That Could Soar 43% to 70%, According to Wall Street

Paramount Global

PennantPark Floating Rate Capital

With soaring profits from its health insurance business, CVS Health can raise its dividend payout at a blazing pace. PennantPark Floating Rate Capital is a business development company with steady cash flows and an eye-popping 11.6% dividend yield.

3 High-Yield Dividend Stocks to Buy and Hold

Walgreens

If you're looking for passive income, these two dividend stocks might be excellent options.

Best Dividend Stock to Buy: Walgreens vs. CVS

AllianceBernstein Hld

Arbor Realty Trust

Ares Capital

Alexandria Real Estate Equities

BHP Billiton

British American Tobacco

ConocoPhillips

Fifth Third Bancorp

Hasbro

Navient

NexPoint Residential Trust

PacWest Bancorp

Pfizer

Philip Morris

Vici Properties

March-April, 2022, UBS, Kiplinger, and Barrons analysts and reporters combined to list five sets of stocks sorted as: “Inflation Busters.” Those five articles revealed 48 equities, with 43 paying dividends.

13 Ideal Inflation-Busting March Dividend Dogs

CVS is a quality BBB S&P credit rated US healthcare convenience “drug store” chain with future growth potential. The price has fallen making it quite an attractive value investment to consider owning with a 11.5% EPS yield.

CVS Health: Attractive Value, 3.2% Yield With 10% Recent Dividend Growth

Costco

Dividends are a significant financial commitment, and many companies can't offer them. CVS has rock-solid sales from its pharmacy business, which isn't going anywhere.

2 Dividend Stocks to Buy for Steady Returns in 2023 and Beyond

CVS is one of the cheapest companies on the market based on simple ratios - its FCF yield is currently 13.6%, and it trades at a 9.0 forward P/E. CVS is also one of the fastest-growing among its peers. During the last 3 years, its revenues, EBITDA, and earnings grew at a CAGR of 7.9%, 9.3%, and 12.5%, respectively.

CVS: Explaining Its Extraordinary 13.6% FCF Yield And Why It's A Buy

Johnson & Johnson

Johnson & Johnson stock offers a 3.0% yield, and it's been over 60 years since the company went more than a year without raising its payout. CVS Health is famous for its pharmacies, but its health insurance benefits management business is what makes it a compelling dividend stock to buy.

3 Reliable Dividend Stocks to Buy and Hold for Decades of Passive Income

Elevance Health Inc

Hormel Foods

Vanguard S&P 500 ETF

Vanguard High Dividend Yield ETF

WestRock

Dividend investing happens, whether the stock market is up or down, whether the Fed raises interest rates or lowers. It's all about buying dividend income-producing stocks – the best source of passive income source on your journey to financial freedom.

Dividend Stock Watch List: Lanny's March 2023 Edition

Medtronic

Medtronic is the world's largest manufacturer of medical devices, and it currently offers a 3.5% yield. CVS Health's dividend has risen 169% over the past decade, and at the moment it offers a 3% yield.

3 High-Yeld Dividend Stocks Near Their 52-Week Lows to Buy on the Dip

Bristol-Myers

Investors are often on the lookout for strong companies that may be undervalued and present lucrative long-term opportunities.

Should Investors Buy Bristol Myers or CVS Stock Near 52-week Lows?

CVS Health has been generating significant sales growth over the years. Its returns haven't been great in the past decade, but the stock could be a market-beating investment in the future.

Could CVS Health Help You Become a Millionaire?

CVS Health's revenue of $83.8 billion in Q4 2022 reflected a 9.5% y-o-y rise, with growth in all segments.

Is CVS Health Stock Undervalued?

Liberum has initiated its coverage of CVS Group (AIM:CVSG) PLC with a ‘buy' recommendation and 2,380p. In doing so, it described the group as more of a trusty Labrador than a mythical unicorn (the latter being a $1bn valued tech start-up).

CVS Group: Unicorn or Labrador? You decide

Shares of CVS Health are down significantly from their peak level in 2022. CVS Health stock pays a dividend that has increased by 169% over the past 10 years.

Is CVS Health a Good Dividend Stock to Buy Now?

Blackrock Inc

Bayerische Motoren Werke AG

Nordstrom

Coca-Cola

Lowe's

Southwest Airlines

Morgan Stanley

Charles Schwab

Toyota Motor

Fortune Magazine February/March 2023 Issue listed 50 World's Most Admired (WMA) companies based on a poll of "some 3,760 corporate executives, directors, and securities analysts." Acclaim from the wider business community, plus standing among rivals, both factored into the ranks. For the sixteenth year in a row, Apple topped all.

News for CVS Health Stock (CVS)